Conduit Pharmaceuticals Inc. (CDT)
NASDAQ: CDT · Real-Time Price · USD
0.0747
+0.0091 (13.87%)
At close: Dec 20, 2024, 4:00 PM
0.0709
-0.0038 (-5.09%)
After-hours: Dec 20, 2024, 7:49 PM EST

Conduit Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21
Net Income
-15.15-0.54-4.89-3.66
Loss (Gain) From Sale of Investments
--0.130.08
Stock-Based Compensation
1.460.2--
Other Operating Activities
3.28-4.631.570.07
Change in Accounts Payable
1.850.22--
Change in Other Net Operating Assets
-2.27-2.730.61.36
Operating Cash Flow
-10.67-7.73-2.27-2.15
Other Investing Activities
0.50.73-0.18-
Investing Cash Flow
0.370.73-0.18-
Long-Term Debt Issued
-2.291.110.69
Net Debt Issued (Repaid)
1.252.291.110.69
Issuance of Common Stock
--1.341.21
Other Financing Activities
0.238.64--
Financing Cash Flow
1.4410.932.451.9
Foreign Exchange Rate Adjustments
0.290.300
Net Cash Flow
-8.574.23--0.25
Free Cash Flow
-10.72-7.73-2.27-2.15
Free Cash Flow Per Share
-0.14-0.11-0.06-
Cash Interest Paid
0.120.12--
Source: S&P Capital IQ. Standard template. Financial Sources.